ArticleNeuro-oncology advances
Building pediatric neuro-oncology capacity in LMICs through multidisciplinary education and collaboration: a mixed-methods analysis.
Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- National and institutional capacity building with international collaboration to advance pediatric neuro-oncology care in Ethiopia: a baseline need assessment survey.Journal of neuro-oncology · 2025Article
- Ten years of pediatric low-grade glioma care in Kenya: Outcomes, progress, and gaps toward achieving global childhood cancer equity.Neuro-oncology pediatrics · 2025Article
- Towards a sub-regional network of neuro-oncology in West Africa: An imperative to bridge the inequalities in care and research and to improve clinical outcomes.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The St. Jude Global Academy's Neuro-Oncology Training Seminar (NOTS) is a course in pediatric neuro-oncology (PNO), which was created for physicians from low- and middle-income countries. This study reports on the impact of the NOTS. Methods: The NOTS has been imparted in 2018, 2022, and 2023. Data on course participants were prospectively collected, and a survey evaluating course impact was completed by graduates and analyzed quantitatively and qualitatively. Results: Overall, participants from 38 institutions from 29 countries have participated in the NOTS. Furthermore, 205 individuals participated, including 70 pediatric oncologists, 45 neurosurgeons, 22 radiation oncologists, 21 pathologists, 17 radiologists, 7 pediatric neurologists, and 23 other specialties. Survey responses from 76 participants were collected. Of the 47% of respondents who did not have multidisciplinary tumor boards (MDTB) before the NOTS, 55% of those institutions created them influenced by their participation in the NOTS. In addition, 79% of respondents stated that multidisciplinary communication improved after the course. Qualitative analysis identified seven key themes related to the impact of the NOTS course and elucidated the impact of the NOTS on multidisciplinary engagement, institutional practice, and patient care. More specifically, respondents described improvements to interpersonal working, co-ordination of care, clinical management, and decision-making. The NOTS participants have continued to be engaged through the Global Alliance in Pediatric Neuro-Oncology (GAPNO). Conclusions: A multidisciplinary course on the care of pediatric CNS tumor for resource-limited settings has increased PNO expertise and improved multidisciplinary care. It has galvanized a community of practice to further expand capacity building.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.